The Potential Association between Tuberculosis and Periodontitis: Implications for Public Health

Tuberculosis and periodontitis are two chronic diseases that have traditionally been viewed as unrelated.However, emerging research indicates a potential association between these conditions, which are significant public health concerns.Tuberculosis, caused by Mycobacterium tuberculosis, primarily affects the lungs but can manifest systemically.Periodontitis is a chronic inflammatory disease of the supporting tissues of the teeth, driven by oral pathogens.Both diseases share common risk factors such as smoking, diabetes, malnutrition, and HIV co-infection, which may exacerbate the bidirectional relationship between the immune system and systemic inflammation.This paper explores the potential pathophysiological connections between tuberculosis and periodontitis and discusses the implications for public health strategies.A literature review was conducted to identify studies linking tuberculosis and periodontitis, focusing on shared immunological pathways, risk factors, and systemic inflammatory processes.Epidemiological studies examining co-occurrence of the diseases in high-risk populations were also analyzed.The findings suggest that chronic inflammation caused by periodontitis may exacerbate systemic conditions like tuberculosis by increasing levels of circulating inflammatory markers, such as C-reactive protein, IL-6, and TNF-.Likewise, individuals with tuberculosis may have a weakened immune system, increasing their susceptibility to periodontal infections.Shared risk factors, particularly smoking, diabetes, and malnutrition, further amplify the burden of both diseases.The immunological dysregulation present in tuberculosis, particularly in the case of immune exhaustion, may impair the body's response to periodontal pathogens, leading to worse oral health outcomes.By adopting a more integrated approach to patient care, dental professionals can help mitigate the systemic impacts of these diseases, reduce the burden of tuberculosis in affected populations, and improve overall patient outcomes.